EP1793855
Forvarnir og meðferð við sjúkdómum sem einkennast af sýnúklein vefjaskemmdum og mýlildismyndun
Status:
EP Einkaleyfi útrunniðEP appl. date:
9.8.2005EP published:
14.11.2018EP application number:
05783732.0
EP translation filed:
31.1.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
8.8.2025Expiry date:
8.8.2025
Title:
PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
Timeline
Today
9.8.2005EP application
14.11.2018EP Publication
31.1.2019Translation submitted
15.2.2019Registration published
8.8.2025Expires
Owner
Name:
Prothena Biosciences LimitedAddress:
Adelphi Plaza Upper George's Street, Dun Laoghaire Co., IE
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, 94607, Oakland, CA, US
Inventor
Name:
SCHENK, Dale, B.Address:
Burlingame, CA, US
Name:
MASLIAH, EliezerAddress:
San Diego, CA, US
Name:
BUTTINI, Manuel, J.Address:
Emeryville, CA, US
Name:
CHILCOTE, Tamie, J.Address:
South San Francisco, CA, US
Name:
ROCKENSTEIN, EdwardAddress:
Chula Vista, CA, US
Name:
GAMES, Kate, DoraAddress:
Belmont, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
915214Date:
9.8.2004Country:
US
Number:
185907Date:
19.7.2005Country:
US
Classification
Categories:
C07K 16/18
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 9.7.2019
Expires: 8.8.2020
Payer: Árnason Faktor
Number: 16
Paid: 8.7.2020
Expires: 8.8.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.7.2021
Expires: 8.8.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 5.7.2022
Expires: 8.8.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 11.7.2023
Expires: 8.8.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 17.7.2024
Expires: 8.8.2025
Payer: Acumass